Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
BCAX compared with SLDB: revenue, margins and what each company keeps, and the suppliers and customers both name
BCAX
Bicara Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
SLDB
Solid Biosciences Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
BCAX
Bicara Therapeutics Inc.
vs
SLDB
Solid Biosciences Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
BCAX, solid
SLDB, dashed
Supply-chain overlap
Revenue flow
BCAX: latest quarter not drawable. SLDB: latest quarter not drawable.
Method
›
BCAX
Bicara Therapeutics Inc.
Change
9.11
▼
−6.38%
· post 8.91
Mkt cap
$620.2M
SLDB
Solid Biosciences Inc.
Change
6.20
▼
−2.97%
· post 6.20
Closed
Oct 30 '26
Mkt cap
$664.8M
vs
Compare
Closed
Oct 30 '26
BCAX
Bicara Therapeutics Inc.
vs
SLDB
Solid Biosciences Inc.
9.11
▼
−6.38%
post 8.91
Price
6.20
▼
−2.97%
post 6.20
$620.2M
Mkt cap
$664.8M
Change
Change
BCAX
9.11
▼
−6.38%
vs
SLDB
6.20
▼
−2.97%
Closed
Oct 30 '26
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only BCAX
2
MSD
MSD International GmbH and MSD International Business GmbH
supplier
—
Biocon
unlisted
supplier
Shared
0
No shared counterparties.
Only SLDB
7
—
FA212
unlisted
supplier
—
ICS Maugeri
unlisted
supplier
—
University of Pennsylvania
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
—
University of Washington
unlisted
supplier
3 more · SLDB chain
›